Mirae Asset Global Investments’s Day One Biopharmaceuticals DAWN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.5K | Buy |
3,916
+525
| +15% | +$3.41K | ﹤0.01% | 1362 |
|
|
2025
Q1 | $27.4K | Buy |
3,391
+30
| +0.9% | +$242 | ﹤0.01% | 1346 |
|
|
2024
Q4 | $43.3K | Sell |
3,361
-250
| -7% | -$3.22K | ﹤0.01% | 1288 |
|
|
2024
Q3 | $51.1K | Buy |
3,611
+1,002
| +38% | +$14.2K | ﹤0.01% | 1299 |
|
|
2024
Q2 | $36.1K | Sell |
2,609
-19,254
| -88% | -$266K | ﹤0.01% | 1301 |
|
|
2024
Q1 | $311K | Sell |
21,863
-22,259
| -50% | -$317K | ﹤0.01% | 2092 |
|
|
2023
Q4 | $644K | Buy |
44,122
+555
| +1% | +$8.1K | ﹤0.01% | 1841 |
|
|
2023
Q3 | $535K | Buy |
43,567
+8,522
| +24% | +$105K | ﹤0.01% | 1851 |
|
|
2023
Q2 | $422K | Buy |
35,045
+12,647
| +56% | +$152K | ﹤0.01% | 2019 |
|
|
2023
Q1 | $299K | Buy |
22,398
+7,106
| +46% | +$95K | ﹤0.01% | 2169 |
|
|
2022
Q4 | $329K | Buy |
15,292
+3,349
| +28% | +$72.1K | ﹤0.01% | 2100 |
|
|
2022
Q3 | $240K | Buy |
+11,943
| New | +$240K | ﹤0.01% | 2261 |
|